Individually-tailored thyroxine requirement in the same patients before and after thyroidectomy: a longitudinal study

Area of Science:

• Endocrinology
• Oncology
• Surgical Science

Background:

• Thyroxine (T4) dosage after differentiated thyroid carcinoma (DTC) surgery is debated.
• Previous studies often used retrospective data and varied treatment approaches.

Purpose of the Study:

• To determine the T4 requirement in DTC patients before and after total thyroidectomy within consistent treatment settings.
• To evaluate T4 needs in the same patients under identical conditions pre- and post-surgery.

Main Methods:

• A longitudinal study involving 23 goitrous patients treated with individually tailored T4 doses.
• Patients maintained stable TSH levels on a consistent T4 dose for at least one year prior to surgery.
• Total thyroidectomy was performed for cancer suspicion or compressive symptoms, followed by standard DTC treatment.

Main Results:

• Three months post-surgery, using the same pre-surgical T4 dose, median TSH significantly increased (P<0.0001).
• The T4 dose required a median increase of 30% (P < 0.0001) to restore pre-surgical TSH levels.
• Both younger and older patients showed increased TSH on the pre-surgical dose, requiring dose adjustments.

Conclusions:

• Thyroidectomized patients require approximately one-third more therapeutic T4 than pre-surgery.
• The adjusted T4 dose remains lower than previously reported for athyreotic patients.
• Consistent treatment regimens are crucial for determining accurate T4 requirements post-thyroidectomy.